Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer - No Study Results Posted

Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer (PROTECT)

This study is ongoing, but not recruiting participants.

Study NCT00779402 Information provided by Dendreon

First Received: October 22, 2008 Last Updated: October 26, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2006 (Final data collection date for primary outcome measure)